NRM
gene geneOn this page
Also known as NRM29
Summary
NRM (nurim, HGNC:8003) is a protein-coding gene on chromosome 6p21.33, encoding Nurim (Q8IXM6).
The protein encoded by this gene contains transmembrane domains and resides within the inner nuclear membrane, where it is tightly associated with the nucleus. This protein shares homology with isoprenylcysteine carboxymethyltransferase enzymes. Alternative splicing results in multiple transcript variants that encode different protein isoforms.
Source: NCBI Gene 11270 — RefSeq curated summary.
At a glance
- GWAS associations: 22
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001384369
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8003 |
| Approved symbol | NRM |
| Name | nurim |
| Location | 6p21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NRM29 |
| Ensembl gene | ENSG00000137404 |
| Ensembl biotype | protein_coding |
| OMIM | 620017 |
| Entrez | 11270 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 7 protein_coding, 5 protein_coding_CDS_not_defined
ENST00000259953, ENST00000376420, ENST00000376421, ENST00000444096, ENST00000462857, ENST00000470733, ENST00000474864, ENST00000482141, ENST00000495946, ENST00000866727, ENST00000921005, ENST00000921006
RefSeq mRNA: 6 — MANE Select: NM_001384369
NM_001270707, NM_001270708, NM_001270709, NM_001270710, NM_001384369, NM_007243
CCDS: CCDS4686, CCDS59498
Canonical transcript exons
ENST00000376421 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001673381 | 30688049 | 30688942 |
| ENSE00001692301 | 30690047 | 30690243 |
| ENSE00002239027 | 30690842 | 30690984 |
| ENSE00003541612 | 30689276 | 30689452 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 90.86.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.8090 / max 178.4199, expressed in 1794 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72582 | 28.5300 | 1794 |
| 72581 | 0.2790 | 116 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| embryo | UBERON:0000922 | 90.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.86 | gold quality |
| blood | UBERON:0000178 | 90.28 | gold quality |
| granulocyte | CL:0000094 | 89.60 | gold quality |
| body of uterus | UBERON:0009853 | 88.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 88.72 | gold quality |
| ectocervix | UBERON:0012249 | 88.63 | gold quality |
| ventricular zone | UBERON:0003053 | 87.99 | gold quality |
| leukocyte | CL:0000738 | 87.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.84 | gold quality |
| monocyte | CL:0000576 | 87.62 | gold quality |
| apex of heart | UBERON:0002098 | 87.62 | gold quality |
| thoracic aorta | UBERON:0001515 | 87.29 | gold quality |
| ascending aorta | UBERON:0001496 | 87.17 | gold quality |
| myometrium | UBERON:0001296 | 87.13 | gold quality |
| endocervix | UBERON:0000458 | 86.90 | gold quality |
| left uterine tube | UBERON:0001303 | 86.78 | gold quality |
| uterine cervix | UBERON:0000002 | 86.47 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.28 | gold quality |
| right ovary | UBERON:0002118 | 86.14 | gold quality |
| right coronary artery | UBERON:0001625 | 86.04 | gold quality |
| placenta | UBERON:0001987 | 86.04 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 85.98 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.98 | gold quality |
| left coronary artery | UBERON:0001626 | 85.93 | gold quality |
| right lung | UBERON:0002167 | 85.86 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.60 | gold quality |
| vagina | UBERON:0000996 | 85.55 | gold quality |
| popliteal artery | UBERON:0002250 | 85.40 | gold quality |
| tibial artery | UBERON:0007610 | 85.39 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-4850 | no | 292.43 |
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting NRM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-5697 | 99.39 | 67.74 | 1249 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-4710 | 98.61 | 65.96 | 1048 |
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-541-5P | 98.24 | 67.77 | 1181 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-7855-5P | 97.39 | 67.18 | 925 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-2278 | 97.30 | 66.19 | 1130 |
| HSA-MIR-4800-5P | 97.22 | 65.91 | 324 |
| HSA-MIR-3184-3P | 96.96 | 66.91 | 845 |
| HSA-MIR-617 | 96.79 | 65.96 | 738 |
| HSA-MIR-3918 | 96.13 | 64.65 | 1300 |
| HSA-MIR-6734-5P | 95.70 | 65.56 | 950 |
| HSA-MIR-659-5P | 95.36 | 65.00 | 300 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
| HSA-MIR-3197 | 94.02 | 63.47 | 85 |
| HSA-MIR-4444 | 92.67 | 67.92 | 56 |
Literature-anchored findings (GeneRIF, showing 2)
- nurim is a polytopic protein tightly associated with the inner nuclear membrane (PMID:15542857)
- these findings implicate that the inner nuclear membrane protein Nurim plays an important role in the suppression of apoptosis (PMID:23092226)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nrm | ENSDARG00000063690 |
| mus_musculus | Nrm | ENSMUSG00000059791 |
| drosophila_melanogaster | CG7655 | FBGN0038536 |
Protein
Protein identifiers
Nurim — Q8IXM6 (reviewed: Q8IXM6)
Alternative names: Nuclear envelope membrane protein, Nuclear rim protein
All UniProt accessions (3): Q8IXM6, A0A1U9X845, H0Y6T6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus inner membrane.
Similarity. Belongs to the nurim family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXM6-1 | 1, a | yes |
| Q8IXM6-2 | 2, b | |
| Q8IXM6-6 | 3, c |
RefSeq proteins (6): NP_001257636, NP_001257637, NP_001257638, NP_001257639, NP_001371298, NP_009174 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033580 | Nurim-like | Family |
UniProt features (17 total): topological domain 7, transmembrane region 6, splice variant 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXM6-F1 | 89.62 | 0.68 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 126 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, PATIL_LIVER_CANCER, FUJII_YBX1_TARGETS_DN, MODULE_397, GOCC_NUCLEAR_ENVELOPE, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_NUCLEAR_INNER_MEMBRANE, GOCC_NUCLEAR_MEMBRANE, GOCC_ORGANELLE_ENVELOPE, FEVR_CTNNB1_TARGETS_DN, VANOEVELEN_MYOGENESIS_SIN3A_TARGETS, CRX_DN.V1_UP, CRX_NRL_DN.V1_UP, RB_P107_DN.V1_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), membrane (GO:0016020), nuclear membrane (GO:0031965), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleus | 2 |
| binding | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| cellular anatomical structure | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NRM | LBR | Q14739 | 645 |
| NRM | EMD | P50402 | 621 |
| NRM | LEMD3 | Q9Y2U8 | 575 |
| NRM | LMNB1 | P20700 | 554 |
| NRM | LMNB2 | Q03252 | 551 |
| NRM | SUN2 | Q9UH99 | 540 |
| NRM | C6orf136 | Q5SQH8 | 518 |
| NRM | SUN1 | O94901 | 488 |
| NRM | SUN3 | Q8TAQ9 | 452 |
| NRM | GNL1 | P36915 | 448 |
| NRM | TCF19 | Q9Y242 | 435 |
| NRM | GTF2H4 | Q92759 | 429 |
| NRM | ABCF1 | Q8NE71 | 416 |
| NRM | BANF1 | O75531 | 411 |
| NRM | GML | Q99445 | 407 |
IntAct
191 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM59 | NRM | psi-mi:“MI:0915”(physical association) | 0.780 |
| NRM | TRIM59 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TMUB1 | ERLIN2 | psi-mi:“MI:0914”(association) | 0.660 |
| CREB3L1 | NRM | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUN2 | NRM | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | SUN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | RTP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | PCDHGA4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | EBP | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | LEPROTL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | SLC39A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | AQP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | SLC6A15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | GPR151 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | MRM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRM | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (79): SUN2 (Two-hybrid), CREB3L1 (Two-hybrid), TRIM59 (Two-hybrid), NRM (Affinity Capture-MS), CRNN (Affinity Capture-MS), NRM (Affinity Capture-MS), ZG16B (Affinity Capture-MS), NRM (Affinity Capture-MS), NRM (Affinity Capture-MS), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid), NRM (Two-hybrid)
ESM2 similar proteins: A0JP80, A1A5Z0, A5D6W6, A7YWN2, B2MVP8, B6CZ46, L5KLU7, O42153, O75783, O75908, O77759, O88908, P58872, P58873, P86243, Q1HG44, Q1KZG0, Q1XHX8, Q32LM8, Q49LS7, Q52KL1, Q5CZN0, Q5KR61, Q5T197, Q5TM67, Q5XIL6, Q6AX73, Q6AZ83, Q6MG14, Q6NSQ9, Q6P5W5, Q767L9, Q7TNJ2, Q7TQM4, Q80YU0, Q86VD9, Q8AVI9, Q8CIP5, Q8IWX5, Q8IXM6
Diamond homologs: A0A0F6P9C0, B1WZQ6, O05883, P87014, Q1XHX8, Q5TM67, Q6MG14, Q767L9, Q89I98, Q89V40, Q8IXM6, Q8VC65, W6VBF4, Q1L911, Q296J9, Q32LM8, Q6GNM0, Q9VEG9, P32584
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
714 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:30689449:CCAG:C | acceptor_gain | 1.0000 |
| 6:30689450:CAGC:C | acceptor_gain | 1.0000 |
| 6:30691147:T:TA | donor_gain | 1.0000 |
| 6:30688939:ATACC:A | acceptor_loss | 0.9900 |
| 6:30688940:TACC:T | acceptor_loss | 0.9900 |
| 6:30688943:C:A | acceptor_loss | 0.9900 |
| 6:30688944:T:A | acceptor_loss | 0.9900 |
| 6:30689450:CAG:C | acceptor_gain | 0.9900 |
| 6:30689453:C:CC | acceptor_gain | 0.9900 |
| 6:30690254:T:C | acceptor_gain | 0.9900 |
| 6:30690847:C:CT | donor_gain | 0.9900 |
| 6:30690848:C:CT | donor_gain | 0.9900 |
| 6:30691103:T:TA | donor_gain | 0.9900 |
| 6:30691125:T:TA | donor_gain | 0.9900 |
| 6:30691126:C:A | donor_gain | 0.9900 |
| 6:30689448:ACCAG:A | acceptor_gain | 0.9800 |
| 6:30689449:CCAGC:C | acceptor_gain | 0.9800 |
| 6:30689451:AGC:A | acceptor_loss | 0.9800 |
| 6:30689452:GCTGT:G | acceptor_loss | 0.9800 |
| 6:30689453:CT:C | acceptor_loss | 0.9800 |
| 6:30689454:T:A | acceptor_loss | 0.9800 |
| 6:30690241:CAT:C | acceptor_gain | 0.9800 |
| 6:30690242:ATCT:A | acceptor_loss | 0.9800 |
| 6:30690244:C:CA | acceptor_loss | 0.9800 |
| 6:30690244:C:CC | acceptor_gain | 0.9800 |
| 6:30690245:T:A | acceptor_loss | 0.9800 |
| 6:30690254:T:TC | acceptor_gain | 0.9800 |
| 6:30691090:C:CT | donor_gain | 0.9800 |
| 6:30690253:G:GC | acceptor_gain | 0.9700 |
| 6:30690805:T:A | donor_gain | 0.9700 |
AlphaMissense
1644 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:30689321:G:C | S154R | 0.998 |
| 6:30689321:G:T | S154R | 0.998 |
| 6:30689323:T:G | S154R | 0.998 |
| 6:30689279:T:A | K168N | 0.997 |
| 6:30689279:T:G | K168N | 0.997 |
| 6:30689304:T:A | D160V | 0.997 |
| 6:30689338:A:G | W149R | 0.997 |
| 6:30689338:A:T | W149R | 0.997 |
| 6:30688828:A:G | W208R | 0.996 |
| 6:30688828:A:T | W208R | 0.996 |
| 6:30688898:C:A | K184N | 0.996 |
| 6:30688898:C:G | K184N | 0.996 |
| 6:30689280:T:A | K168I | 0.996 |
| 6:30689287:C:G | G166R | 0.996 |
| 6:30689304:T:G | D160A | 0.995 |
| 6:30689305:C:G | D160H | 0.994 |
| 6:30689303:G:C | D160E | 0.993 |
| 6:30689303:G:T | D160E | 0.993 |
| 6:30689305:C:A | D160Y | 0.993 |
| 6:30689362:A:G | C141R | 0.993 |
| 6:30689292:A:G | L164P | 0.991 |
| 6:30688860:T:C | H197R | 0.990 |
| 6:30690084:C:A | R98M | 0.990 |
| 6:30688861:G:C | H197D | 0.989 |
| 6:30689287:C:A | G166C | 0.988 |
| 6:30689435:C:A | W116C | 0.988 |
| 6:30689435:C:G | W116C | 0.988 |
| 6:30688737:T:A | D238V | 0.987 |
| 6:30688864:G:T | R196S | 0.987 |
| 6:30690891:A:C | F28L | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1002322612 (6:30691176 T>C), RS1004005392 (6:30692238 C>T), RS1004067064 (6:30692936 G>A), RS1005031678 (6:30688402 T>G), RS1005569430 (6:30693096 G>A), RS1005683947 (6:30693374 C>G), RS1007075984 (6:30690353 G>A,T), RS1007429056 (6:30688859 G>A,T), RS1008082113 (6:30692072 A>G,T), RS1008460150 (6:30690191 G>A,T), RS1009918633 (6:30689893 T>G), RS1010610160 (6:30691915 C>G,T), RS1010887315 (6:30689617 G>C), RS1011795871 (6:30691443 G>A), RS1013104977 (6:30687795 C>T)
Disease associations
OMIM: gene MIM:620017 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
22 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003538_2 | Alcohol dependence symptom count | 3.000000e-10 |
| GCST004521_114 | Autism spectrum disorder or schizophrenia | 3.000000e-17 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_121 | Autism spectrum disorder or schizophrenia | 3.000000e-13 |
| GCST004521_132 | Autism spectrum disorder or schizophrenia | 2.000000e-09 |
| GCST004521_171 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_2 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_209 | Autism spectrum disorder or schizophrenia | 5.000000e-16 |
| GCST004521_210 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_263 | Autism spectrum disorder or schizophrenia | 7.000000e-17 |
| GCST004521_265 | Autism spectrum disorder or schizophrenia | 7.000000e-14 |
| GCST004521_269 | Autism spectrum disorder or schizophrenia | 7.000000e-11 |
| GCST004521_295 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_3 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_48 | Autism spectrum disorder or schizophrenia | 1.000000e-09 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_70 | Autism spectrum disorder or schizophrenia | 8.000000e-20 |
| GCST004521_79 | Autism spectrum disorder or schizophrenia | 1.000000e-16 |
| GCST004861_77 | Itch intensity from mosquito bite | 2.000000e-08 |
| GCST007326_6 | Number of sexual partners | 2.000000e-08 |
| GCST008053_76 | Height | 2.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007835 | alcohol dependence measurement |
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects expression, decreases expression, increases abundance, increases expression | 4 |
| bisphenol A | affects expression, decreases methylation | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Arsenic | decreases expression, increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| phenethyl isothiocyanate | decreases expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| K 7174 | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Calcitriol | affects cotreatment, decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Coumestrol | increases expression, affects cotreatment | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Dronabinol | increases expression | 1 |
| Thimerosal | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.